Clinical Trial Update: NGR-hTNF Administered in Combination With a Standard Oxaliplatin Based Regimen in Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated NGR-hTNF in combination with an oxaliplatin-based regimen for metastatic colorectal cancer and the study is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• NGR-hTNF (NGR-hTNF)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: AGC Biologics S.p.A. | Conditions: Colon Cancer | Phase 2 | Status: COMPLETED